Article information
Abstract
Current treatment for human immunodeficiency virus (HIV) infection has improved survival and allowed infected patients to develop atherosclerotic coronary artery disease (CAD). Specific strategies to reduce cardiovascular risk in the infected population have not been developed. It is necessary to know the magnitude of cardiovascular risk in this population.
ObjectivesThis study aimed to assess cardiovascular risk using a well-known clinical score and to investigate coronary artery calcium scoring (CACS) in this population.
MethodsThis was a cross-sectional study. Adults with HIV infection were studied. Demographic, clinical and anthropometric data, serum glucose and lipids were obtained. Cardiovascular risk was calculated through Framingham risk score (FRS) and CACS. Categorical variables were compared by Chi-square or Fisher's exact test, and continuous variables were analyzed by Student t test or Mann-Whitney test. An analysis of concordance between FRS and CACS was performed using kappa statistic.
ResultsForty patients, aged 45.9±8.1 years, were studied. Age of risk for CAD were found in 30.0%, hypertension in 55.0%, diabetes in 10.0%, smoking in 35.0%, dyslipidemia in 67.5% and family history of CAD in 57.5%. Altered levels of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides were found in 30.0%, 25.0% and 82.5%, respectively. HDL-cholesterol and triglycerides were altered more frequently among protease inhibitors users. The FRS classified the risk as low for 72.5%, moderate for 25.0%, and high for 2.5%. CACS>0 was found in 32.5% of the patients, in 67.5% the score was low, in 17.5% moderate, and in 15.0% high. Concordance between FRS and CACS showed a kappa = 0.435.
ConclusionsThere is a high prevalence of risk factors for CAD in the studied population, with dyslipidemia being the most frequent. HDL-cholesterol and triglycerides were the most frequently altered factors and were associated with the use of protease inhibitors. Risk assessed by the FRS was low in most cases. CACS>0 was found in 32.5%, demonstrating the need to re-evaluate the strategies for assessing cardiovascular risk in the HIV-infected population.
Keywords:
coronary artery disease
HIV
cardiovascular diseases
HIV protease inhibitors
Full text is only aviable in PDF
References
[1.]
The Joint United Nations Programme on HIV/AIDS. UNAIDS. AIDS epidemic update [Internet]. Geneva: [updated on 2010; cited 2011 Jan 11]. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en1.pdf.
[2.]
Ministério da Saúde. Aids.gov: Aids no Brasil [Internet]. Brasília: Ministério da Saúde. [cited 2011 Jan 11]. Available from: http://www.aids.gov.br/pagina/aids-no-brasil.
[3.]
Ministério da Saúde. Monitoraids [Internet]. Brasília: Ministério da Saúde [cited 2011 Jan 10]. Available from: http://sistemas.aids.gov.br/monitoraids/?keyWord=gasto&condicaoFicha=nomeIndicador&desagregacao=1.
[4.]
N. Lohse, A.B. Hansen, G. Pedersen, et al.
Survival of persons with and without HIV infection in Denmark, 1995–2005.
Ann Intern Med, 146 (2007), pp. 87-95
[5.]
J.S. Currier, A. Taylor, F. Boyd, et al.
Coronary heart diseases in HIV- infected individuals.
J Acquir Immune Defic Syndr, 33 (2003), pp. 506-512
[6.]
V.A. Triant, H. Lee, C. Hadigan, S.K. Grinspoon.
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.
J Clin Endocrinol Metab, 92 (2007), pp. 2506-2512
[7.]
A. D’Arminio, C.A. Sabin, A.N. Phillips, Writing Committee of the D:A:D: Study Group, et al.
Cardio and cerebrovascular events in HIV-infected persons.
AIDS, 18 (2004), pp. 1811-1817
[8.]
A.C. Sposito, B. Caramelli, F.A. Fonseca, et al.
Sociedade Brasileira de Cardiologia. IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology.
Arq Bras Cardiol, 88 (2007), pp. 2-19
[9.]
Grupo de Estudo em Ressonância e Tomografia Cardiovascular (GERT) do Departamento de Cardiologia Clínica da Sociedade Brasileira de Cardiologia.
Cardiovascular magnetic resonance and computed tomography imaging guidelines of the Brazilian Society of Cardiology.
Arq Bras Cardiol, 87 (2006), pp. e60-e100
[10.]
Ministério da Saúde, Secretaria de Vigilância em Saúde.
Programa Nacional de DST e Aids. Recomendações para terapia anti-retroviral em adultos infectados pelo HIV: 2008.
Ministério da Saúde, (2008),
[11.]
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
Circulation, 106 (2002), pp. 3143-3421
[12.]
H.W. Rodbard, L. Blonde, S.S. Braithwaite, et al.
AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
Endocr Pract, 13 (2007), pp. 1-68
[13.]
American Diabetes Association.
Standards of medical care in diabetes—2006.
Diabetes Care, 29 (2006), pp. S4-S42
[14.]
K.V. Bailey, A. Ferro-Luzzi.
Use of body mass index of adults in assessing individual and community nutritional status.
Bull World Health Organ, 73 (1995), pp. 673-680
[15.]
National Institutes of Health.
Clinical guidelines on the indentification, evaluation, and treatment of overweight and obesity in adults – the evidence report.
Obesity Res, 6 (1998), pp. 51S-209S
[16.]
I. Janssen, P.T. Katzmarzyk, R. Ross.
Waist circunference and not body mass index explains obesity-related health risk.
Am J Clin Nutr, 79 (2004), pp. 379-384
[17.]
T.G. Lohman, A.F. Roche, R. Martorell.
Anthropometric standardization reference manual.
Human Kinetics Book, (1998),
[18.]
Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão.
Sociedade Brasileira de Nefrologia. VI Diretriz Brasileira de Hipertensão Arterial.
Arq Bras Cardiol, 95 (2010), pp. 1-51
[19.]
American Diabetes Association.
Screening for type 2 diabetes.
Diabetes Care, 27 (2004), pp. S11-S14
[20.]
W.P. Castelli.
Cardiovascular disease and multifactorial risk: challenge of the 1980s.
Am Heart J, 106 (1983), pp. 1191-1200
[21.]
S. Achenbach, W.G. Daniel.
Tomografia Computadorizada do Coração.
Braunwald tratado de doenças cardiovasculares, 7ª ed., pp. 355-371
[22.]
A.S. Agatston, W.R. Janowitz, F.J. Hildner, et al.
Quantification of coronary artery calcium using ultrafast computed tomography.
J Am Coll Cardiol, 15 (1990), pp. 827-832
[23.]
J.Á. Rumberger, L. Kaufman.
A rosetta stone calcium risk stratification: Agatston, volume, and mass score in 11,490 individuals.
AJR Am J Roentgenol, 181 (2003), pp. 743-748
[24.]
K. Nasir, P. Raggi, J.A. Rumberger, et al.
Coronary artery calcium volume scores on electron beam tomography in 12,936 asymptomatic adults.
Am J Cardiol, 93 (2004), pp. 1146-1149
[25.]
J.A. Hoff, E.V. Chomka, A.J. Krainik, et al.
Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults.
Am J Cardiol, 87 (2001), pp. 1335-1339
[26.]
J.A. Rumberger, B.H. Brundage, D.J. Rader, et al.
Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons.
Mayo Clin Proc, 74 (1999), pp. 243-252
[27.]
Sociedade Brasileira de Cardiologia.
Departamento de Cardiologia Clinica. Grupo de Estudo de Ressonância e Tomografia Cardiovascular (GERT). Guideline of Sociedade Brasileira de Cardiologia for resonance and cardiovascular tomography. Exucutive summary.
Arq Bras Cardiol, 87 (2006), pp. e1-e12
[28.]
R.A. O’Rourke, B.H. Brundage, V.F. Froelicher, et al.
American College of Cardiology/American Heart Association Expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease.
Circulation, 102 (2000), pp. 126-140
[29.]
J. Truett, J. Cornfield, W. Kannel.
A multivariate analysis of the risk of coronary heart disease in Framingham.
J Chronic Dis, 20 (1967), pp. 511-524
[30.]
R.B. D’Agostino Sr., S. Grundy, L.M. Sullivan, et al.
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.
JAMA, 286 (2001), pp. 180-187
[31.]
R Development Core Team (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/.
[32.]
A. Mangili, J. Gerrior, A.M. Tang, et al.
Risk of cardiovascular disease in a cohort of HIV-infected adults; a study using carotid intima-media thickness and coronary artery calcium score.
Clin Infect Dis, 43 (2006), pp. 1482-1489
[33.]
A. Mangili, J. Gerrior, A.M. Tang, et al.
Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.
Clin Infect Dis, 44 (2007), pp. 1368-1374
[34.]
J.H. Steinn, C.M. Hadigan, T.T. Brown, et al.
Prevention strategies for cardovascular disease in HIV-infected patients.
Circulation, 118 (2008), pp. e54-e60
[35.]
R.C. Kaplan, L.A. Kingsley, A.R. Sharrett, et al.
Ten-year predicted coronary heart disease risk in HIV-infected men and women.
Clin Infect Dis, 45 (2007), pp. 1074-1081
[36.]
T.M. Rosáorio, L.C.N.S. Scala, G.V.A. França, et al.
Prevalência, controle e tratamento da hipertensão arterial sistêmica em Nobres - MT.
Arq Bras Cardiol, 93 (2009), pp. 672-678
[37.]
E.R. Gritz, D.J. Vidrine, A.B. Lazev, et al.
Smoking behavior in a low-income multiethnic HIV/AIDS population.
Nicotine Tab Res, 6 (2004), pp. 71-77
[38.]
Ministério da Saúde. INCA. Publicações, e Pesquisa nacional por amostra de domicílio/tabagismo [internet]. Brasília: Ministério da saúde. [cited 2011 Jan 15]. Available from: http://www.inca.gov.br/inca/Arquivos/publicacoes/tabagismo.pdf.
[39.]
P. Cahn, O. Leite, A. Rosales, et al.
Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART.
Braz J Infect Dis, 14 (2010), pp. 158-166
[40.]
L.A. Kingsley, J. Cuervo-Rojas, A. Muñoz, et al.
Subclinical coronary atherosclerosis. HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study.
AIDS, 22 (2008), pp. 1589-1599
[41.]
K. Mulligan, C. Grunfeld, V.W. Tai, et al.
Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.
J Acquir Immune Defic Syndr, 23 (2000), pp. 35-43
[42.]
D. Periard, A. Telenti, P. Sudre, et al.
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors: the Swiss HIV Cohort Study.
Circulation, 100 (1999), pp. 700-705
[43.]
M. van der Valk, J.J. Kastelein, R.L. Murphy, et al.
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in anti-atherogenic lipid profile.
AIDS, 15 (2001), pp. 5186-5192
[44.]
D.A. Duprez, L.H. Kuller, R. Tracy, et al.
Lipoproteina particle subclasses, cardiovascular disease and HIV infection.
Atherosclerosis, 207 (2009), pp. 524-529
[45.]
S.A. Danner, A. Carr, J.M. Leonard, et al.
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, na inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group.
N Engl J Med, 333 (1995), pp. 1528-1533
[46.]
P.H. Davis, J.D. Dawson, L.T. Mahoney, et al.
Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults: The uscatine study.
Circulation, 100 (1999), pp. 838-842
[47.]
C.M. Loria, K. Liu, C.E. Lewis, et al.
Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA study.
J AM Coll Cardiol, 49 (2007), pp. 2013-2020
[48.]
N. Crum-Cianflone, J. Stepenosky, S. Medina, et al.
Clinically significant incidental findings among human immunodeficiency virus-infected mem during computed tomography for determination of coronary artery calcium.
Am J Cardiol, 107 (2011), pp. 633-637
[49.]
R.L. McClelland, H. Chung, R. Detrano, et al.
Distribution of coronary artery calcium by race, gender, and age: results from Multi-Ethnic Study of Atherosclerosis (MESA).
Circulation, 113 (2006), pp. 30-37
[50.]
P. Greenland, R.O. Bonow, B.H. Brundage, et al.
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography.
J Am Coll Cardiol, 49 (2007), pp. 378-402
[51.]
P. Raggi, L.J. Shaw, D.S. Berman, et al.
Prognostic value of coronary artery calcium screening in subjects with and without diabetes.
J Am Coll Cardiol, 43 (2004), pp. 1663-1669
[52.]
P. Raggi, B. Cooil, T.Q. Callister.
Use of electron beam tomography data to develop models for prediction of hard coronary vents.
Am Heart J, 141 (2001), pp. 375-382
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
